Zurueck zur Suche

Reporte zur Charge EN62085

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MA 1

VAERS 1929326

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN62085

mild
Staat
MA
Alter
47,0
Geschlecht
F
Eingang
07.12.2021
Impfdatum
28.02.2021
Beginn
30.11.2021
Tage bis Beginn
275,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Blood culture negative Blood sodium decreased COVID-19 Chest X-ray normal Headache Hyponatraemia Hypophagia Immunisation reaction Immunodeficiency Infection Nausea Nervousness Pyrexia SARS-CoV-2 test positive Viral infection Vomiting

Symptomtext

48F with PMH of cystic fibrosis s/p BLTx 2012, HTN, chronic sinusitis, and transaminitis, who presents with low grade fever, nausea, vomiting, unable to tolerate PO x1 day. Found to have +COVID, given monoclonal antibodies and symptoms resolved by discharge #Fever, nausea, vomiting, headache Patient reported nausea/vomiting x1 day, tried to eat crackers and minimal liquids, unable to tolerate PO and was nervous about not being able to keep down transplant medications, therefore presented to ED. Also with associated headache and noted fever with Tmax 100.3F, improved with tylenol. On admission, nausea improving with PO zofran and continued home PPI. Hyponatremic (Na 129). Given NS 500 cc bolus for hydration. Empirically given IV Ceftaz 2g x1 for immunocompromised with fever. Blood cultures x2 with NGTD. Found to be +COVID as noted below, GI sxs likely related to viral infection. Improved at discharge, given Rx for PO zofran to use at home. #COVID Found to be COVID+ on admission. Afebrile, no URI symptoms, satting well on RA. CXR with no acute findings. She had COVID last year (no symptoms, tested due to exposure to coworker) and was also vaccinated x2 (Pfizer) but had not yet gotten booster due to significant reaction after both vaccines and wanted to test antibody level first. Given mAb (12/1) for prevention of worsening infection, tolerated well without complication. Did not meet criteria/require dexamethasone or Remdesivir.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
2,0
Labordaten
COVID+ 11/30/21
Aktuelle Erkrankungen
cystic fibrosis
Vorgeschichte
Diagnosis Date ? Adrenal hypofunction 11/30/2011 ? Asthma 9/6/2007 ? Chronic sinusitis 11/30/2011 ? Cystic fibrosis 9/6/2007 Carries one copy of Delta F508 mutation ? Lung replaced by transplant 7/18/2012 B/L 7/18/2012 CMV: D+/R+ EBV: D+/R+ Toxo: NEG ? Sensorineural hearing loss 3/21/2014
Andere Medikamente
? azaTHIOprine (IMURAN) 50 mg tablet Take 1 tablet (50 mg total) by mouth 2 (two) times a day. ? azithromycin (ZITHROMAX) 250 MG tablet TAKE 1 TABLET (250 MG TOTAL) BY MOUTH 3 (THREE) TIMES A WEEK ON MONDAY, WEDNESDAY, FRIDAY. ? calcium car
Allergien
augmentin, peanuts, rituximab, sulfa
Vorherige Impfungen
-